Enhanced Electrical Stimulation Modulation with Adaptive Power Management and Personalized Therapy

Publication ID: 24-11857790_0006_PTD
Published: October 28, 2025
Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Enhanced Electrical Stimulation Modulation with Adaptive Power Management and Personalized Therapy,” Published Technical Disclosure No. 24-11857790_0006_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857790_0006_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,790.

Summary of the Inventive Concept

The present inventive concept discloses a novel electrical stimulation modulation system that optimizes energy consumption, dynamically adjusts stimulation parameters based on real-time physiological feedback, and leverages machine learning algorithms to predict optimal therapy settings. This enhanced system improves the efficiency, safety, and efficacy of electrical stimulation therapy.

Background and Problem Solved

The original patent disclosed an electrical stimulation modulation system that delivered therapy based on predetermined parameters. However, this system had limitations in terms of energy consumption, adaptability to changing patient needs, and therapeutic efficacy. The present inventive concept addresses these limitations by introducing adaptive power management, real-time physiological feedback, and machine learning-driven personalized therapy.

Detailed Description of the Inventive Concept

The enhanced system comprises a power management module that optimizes energy consumption based on the patient's stimulation requirements. The system also includes a real-time feedback mechanism that dynamically adjusts stimulation parameters based on the patient's physiological response. Additionally, the system incorporates a machine learning algorithm that predicts optimal stimulation parameters for a patient based on historical data and biomarkers. The system further synchronizes stimulation pulses with the patient's natural brain activity to enhance therapeutic efficacy. The inventive concept also enables personalized therapy by identifying a patient's unique brain activity patterns and tailoring the stimulation parameters accordingly.

Novelty and Inventive Step

The present inventive concept introduces several novel features that distinguish it from the original patent. The adaptive power management module, real-time physiological feedback mechanism, and machine learning-driven personalized therapy represent a significant departure from the predetermined parameter-based approach of the original patent. These features provide a non-obvious solution to the limitations of the original patent, enhancing the overall efficiency, safety, and efficacy of electrical stimulation therapy.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may include variations in the power management module, such as using advanced battery technologies or energy harvesting mechanisms. Other variations may involve different machine learning algorithms or incorporating additional biomarkers for personalized therapy. The inventive concept could also be adapted for use in different medical applications, such as cardiac or neurological disorders.

Potential Commercial Applications and Market

The enhanced electrical stimulation modulation system has significant commercial potential in the medical device industry, particularly in the areas of neurological and cardiac disorders. The system's improved efficiency, safety, and efficacy make it an attractive solution for patients and healthcare providers. The market for electrical stimulation therapy devices is expected to grow significantly in the coming years, driven by increasing demand for minimally invasive and personalized treatment options.

Original Patent Information

Patent NumberUS 11,857,790
TitleElectrical stimulation modulation
Assignee(s)Medtronic, Inc.